TY - JOUR
T1 - Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design
AU - Kooijmans, Sander A A
AU - de Jong, Olivier G
AU - Schiffelers, Raymond M
N1 - Funding Information:
SAAK was supported by a Veni grant in the Applied and Engineering Sciences Domain of the Dutch Research Council (NWO)[grant number 17296]; OGJ was supported by a Veni grant in the Science. Domain of the Dutch Research Council (NWO) (grant number VI.Veni.192.174). RMS is supported by by the project B-SMART and EXPERT as part of the European Union's Horizon 2020 research and innovation programme under grant agreement No 721058 and 825858, respectively. Dr. Pieter Vader is thanked for fruitful discussions and valuable input for this review.
Publisher Copyright:
© 2021 The Authors
PY - 2021/6
Y1 - 2021/6
N2 - Extracellular vesicles (EVs) are submicron cell-secreted structures containing proteins, nucleic acids and lipids. EVs can functionally transfer these cargoes from one cell to another to modulate physiological and pathological processes. Due to their presumed biocompatibility and capacity to circumvent canonical delivery barriers encountered by synthetic drug delivery systems, EVs have attracted considerable interest as drug delivery vehicles. However, it is unclear which mechanisms and molecules orchestrate EV-mediated cargo delivery to recipient cells. Here, we review how EV properties have been exploited to improve the efficacy of small molecule drugs. Furthermore, we explore which EV surface molecules could be directly or indirectly involved in EV-mediated cargo transfer to recipient cells and discuss the cellular reporter systems with which such transfer can be studied. Finally, we elaborate on currently identified cellular processes involved in EV cargo delivery. Through these topics, we provide insights in critical effectors in the EV-cell interface which may be exploited in nature-inspired drug delivery strategies.
AB - Extracellular vesicles (EVs) are submicron cell-secreted structures containing proteins, nucleic acids and lipids. EVs can functionally transfer these cargoes from one cell to another to modulate physiological and pathological processes. Due to their presumed biocompatibility and capacity to circumvent canonical delivery barriers encountered by synthetic drug delivery systems, EVs have attracted considerable interest as drug delivery vehicles. However, it is unclear which mechanisms and molecules orchestrate EV-mediated cargo delivery to recipient cells. Here, we review how EV properties have been exploited to improve the efficacy of small molecule drugs. Furthermore, we explore which EV surface molecules could be directly or indirectly involved in EV-mediated cargo transfer to recipient cells and discuss the cellular reporter systems with which such transfer can be studied. Finally, we elaborate on currently identified cellular processes involved in EV cargo delivery. Through these topics, we provide insights in critical effectors in the EV-cell interface which may be exploited in nature-inspired drug delivery strategies.
KW - Extracellular vesicles
KW - Exosomes
KW - Drug delivery
KW - Extracellular vesicle surface
KW - Reporter systems
KW - Uptake mechanisms
KW - RNA delivery
KW - Protein delivery
KW - Small molecules
UR - http://www.scopus.com/inward/record.url?scp=85103788359&partnerID=8YFLogxK
U2 - 10.1016/j.addr.2021.03.017
DO - 10.1016/j.addr.2021.03.017
M3 - Review article
C2 - 33798644
SN - 0169-409X
VL - 173
SP - 252
EP - 278
JO - Advanced Drug Delivery Reviews
JF - Advanced Drug Delivery Reviews
ER -